{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:43:41Z","timestamp":1790081021050,"version":"4.0.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31571202"],"award-info":[{"award-number":["31571202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31271136"],"award-info":[{"award-number":["31271136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Municipal Commission of Education","award":["KZ201210025020"],"award-info":[{"award-number":["KZ201210025020"]}]},{"name":"Young Talents Cultivation Plan for Beijing Local University","award":["CIT&TCD201504087"],"award-info":[{"award-number":["CIT&TCD201504087"]}]},{"name":"Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality","award":["IDHT20140514"],"award-info":[{"award-number":["IDHT20140514"]}]},{"name":"National Natural Science Foundation of China (CN)","award":["81371398"],"award-info":[{"award-number":["81371398"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00018-016-2345-4","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T13:26:50Z","timestamp":1472131610000},"page":"683-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Aptamer and its applications in neurodegenerative diseases"],"prefix":"10.1007","volume":"74","author":[{"given":"Jing","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"issue":"4","key":"2345_CR1","doi-asserted-by":"publisher","first-page":"6866","DOI":"10.3390\/molecules20046866","volume":"20","author":"JG Bruno","year":"2015","unstructured":"Bruno JG (2015) Predicting the uncertain future of aptamer-based diagnostics and therapeutics. Molecules 20(4):6866\u20136887. doi: 10.3390\/molecules20046866","journal-title":"Molecules"},{"key":"2345_CR2","doi-asserted-by":"publisher","first-page":"540451","DOI":"10.1155\/2014\/540451","volume":"2014","author":"B Santosh","year":"2014","unstructured":"Santosh B, Yadava PK (2014) Nucleic acid aptamers: research tools in disease diagnostics and therapeutics. Biomed Res Int 2014:540451. doi: 10.1155\/2014\/540451","journal-title":"Biomed Res Int"},{"issue":"3","key":"2345_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3892\/mco.2014.255","volume":"2","author":"X Pei","year":"2014","unstructured":"Pei X, Zhang J, Liu J (2014) Clinical applications of nucleic acid aptamers in cancer. Mol Clin Oncol 2(3):341\u2013348. doi: 10.3892\/mco.2014.255","journal-title":"Mol Clin Oncol"},{"issue":"6574","key":"2345_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/380548a0","volume":"380","author":"P Colas","year":"1996","unstructured":"Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380(6574):548\u2013550. doi: 10.1038\/380548a0","journal-title":"Nature"},{"issue":"6287","key":"2345_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/346818a0","volume":"346","author":"AD Ellington","year":"1990","unstructured":"Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346(6287):818\u2013822. doi: 10.1038\/346818a0","journal-title":"Nature"},{"issue":"14","key":"2345_CR6","first-page":"4029","volume":"62","author":"SE Lupold","year":"2002","unstructured":"Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62(14):4029\u20134033","journal-title":"Cancer Res"},{"issue":"4","key":"2345_CR7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1017\/S1355838200991763","volume":"6","author":"C Mannironi","year":"2000","unstructured":"Mannironi C, Scerch C, Fruscoloni P, Tocchini-Valentini GP (2000) Molecular recognition of amino acids by RNA aptamers: the evolution into an l-tyrosine binder of a dopamine-binding RNA motif. RNA 6(4):520\u2013527","journal-title":"RNA"},{"issue":"6","key":"2345_CR8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/nar\/24.6.1029","volume":"24","author":"A Geiger","year":"1996","unstructured":"Geiger A, Burgstaller P, von der Eltz H, Roeder A, Famulok M (1996) RNA aptamers that bind l-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res 24(6):1029\u20131036","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"2345_CR9","doi-asserted-by":"crossref","first-page":"11285","DOI":"10.1073\/pnas.94.21.11285","volume":"94","author":"KP Williams","year":"1997","unstructured":"Williams KP, Liu XH, Schumacher TN, Lin HY, Ausiello DA, Kim PS, Bartel DP (1997) Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci USA 94(21):11285\u201311290","journal-title":"Proc Natl Acad Sci USA"},{"key":"2345_CR10","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1039\/b604778e","volume":"30","author":"P Mallikaratchy","year":"2006","unstructured":"Mallikaratchy P, Stahelin RV, Cao Z, Cho W, Tan W (2006) Selection of DNA ligands for protein kinase C-delta. Chem Commun 30:3229\u20133231. doi: 10.1039\/b604778e","journal-title":"Chem Commun"},{"issue":"16","key":"2345_CR11","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1021\/bi00016a041","volume":"34","author":"D Nieuwlandt","year":"1995","unstructured":"Nieuwlandt D, Wecker M, Gold L (1995) In vitro selection of RNA ligands to substance P. Biochemistry 34(16):5651\u20135659","journal-title":"Biochemistry"},{"issue":"6","key":"2345_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/cmdc.200800030","volume":"3","author":"HW Chen","year":"2008","unstructured":"Chen HW, Medley CD, Sefah K, Shangguan D, Tang Z, Meng L, Smith JE, Tan W (2008) Molecular recognition of small-cell lung cancer cells using aptamers. Chem Med Chem 3(6):991\u20131001. doi: 10.1002\/cmdc.200800030","journal-title":"Chem Med Chem"},{"issue":"13","key":"2345_CR13","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1021\/ac070189y","volume":"79","author":"Z Tang","year":"2007","unstructured":"Tang Z, Shangguan D, Wang K, Shi H, Sefah K, Mallikratchy P, Chen HW, Li Y, Tan W (2007) Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem 79(13):4900\u20134907. doi: 10.1021\/ac070189y","journal-title":"Anal Chem"},{"issue":"32","key":"2345_CR14","doi-asserted-by":"publisher","first-page":"11838","DOI":"10.1073\/pnas.0602615103","volume":"103","author":"D Shangguan","year":"2006","unstructured":"Shangguan D, Li Y, Tang Z, Cao ZC, Chen HW, Mallikaratchy P, Sefah K, Yang CJ, Tan W (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103(32):11838\u201311843. doi: 10.1073\/pnas.0602615103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2345_CR15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/EC.2.1.84-94.2003","volume":"2","author":"M Lorger","year":"2003","unstructured":"Lorger M, Engstler M, Homann M, Goringer HU (2003) Targeting the variable surface of African trypanosomes with variant surface glycoprotein-specific, serum-stable RNA aptamers. Eukaryot Cell 2(1):84\u201394","journal-title":"Eukaryot Cell"},{"issue":"9","key":"2345_CR16","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2217\/nnm.10.115","volume":"5","author":"JR Kanwar","year":"2010","unstructured":"Kanwar JR, Mohan RR, Kanwar RK, Roy K, Bawa R (2010) Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases. Nanomedicine 5(9):1435\u20131445. doi: 10.2217\/nnm.10.115","journal-title":"Nanomedicine"},{"issue":"5","key":"2345_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0956-5663(99)00028-7","volume":"14","author":"JG Bruno","year":"1999","unstructured":"Bruno JG, Kiel JL (1999) In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. Biosens Bioelectron 14(5):457\u2013464","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"2345_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00239-008-9130-4","volume":"67","author":"MC Cowperthwaite","year":"2008","unstructured":"Cowperthwaite MC, Ellington AD (2008) Bioinformatic analysis of the contribution of primer sequences to aptamer structures. J Mol Evol 67(1):95\u2013102. doi: 10.1007\/s00239-008-9130-4","journal-title":"J Mol Evol"},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.bios.2014.09.026","volume":"64","author":"SY Toh","year":"2015","unstructured":"Toh SY, Citartan M, Gopinath SC, Tang TH (2015) Aptamers as a replacement for antibodies in enzyme-linked immunosorbent assay. Biosens Bioelectron 64:392\u2013403. doi: 10.1016\/j.bios.2014.09.026","journal-title":"Biosens Bioelectron"},{"issue":"6","key":"2345_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/nat.2014.0492","volume":"24","author":"EM McConnell","year":"2014","unstructured":"McConnell EM, Holahan MR, DeRosa MC (2014) Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system. Nucleic acid Ther 24(6):388\u2013404. doi: 10.1089\/nat.2014.0492","journal-title":"Nucleic acid Ther"},{"issue":"2","key":"2345_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/OPTH.S2842","volume":"2","author":"N Feucht","year":"2008","unstructured":"Feucht N, Matthias H, Lohmann CP, Maier M (2008) Pegaptanib sodium treatment in neovascular age-related macular degeneration: clinical experience in Germany. Clin Ophthalmol 2(2):253\u2013259","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"2345_CR22","doi-asserted-by":"publisher","first-page":"1508 e1501\u2013e152","DOI":"10.1016\/j.ophtha.2006.02.064","volume":"113","author":"U Chakravarthy","year":"2006","unstructured":"Group VISiONCT, Chakravarthy U, Adamis AP, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Patel M (2006) Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113(9):1508 e1501\u2013e1525. doi: 10.1016\/j.ophtha.2006.02.064","journal-title":"Ophthalmology"},{"issue":"27","key":"2345_CR23","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","volume":"351","author":"ES Gragoudas","year":"2004","unstructured":"Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, Group VISiONCT (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27):2805\u20132816. doi: 10.1056\/NEJMoa042760","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"2345_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00604-013-1156-7","volume":"181","author":"J Wu","year":"2014","unstructured":"Wu J, Zhu Y, Xue F, Mei Z, Yao L, Wang X, Zheng L, Liu J, Liu G, Peng C, Chen W (2014) Recent trends in SELEX technique and its application to food safety monitoring. Mikrochim Acta 181(5\u20136):479\u2013491. doi: 10.1007\/s00604-013-1156-7","journal-title":"Mikrochim Acta"},{"issue":"4968","key":"2345_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","volume":"249","author":"C Tuerk","year":"1990","unstructured":"Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249(4968):505\u2013510","journal-title":"Science"},{"issue":"11","key":"2345_CR26","doi-asserted-by":"publisher","first-page":"e13863","DOI":"10.1371\/journal.pone.0013863","volume":"5","author":"R Shaltiel-Karyo","year":"2010","unstructured":"Shaltiel-Karyo R, Frenkel-Pinter M, Egoz-Matia N, Frydman-Marom A, Shalev DE, Segal D, Gazit E (2010) Inhibiting alpha-synuclein oligomerization by stable cell-penetrating beta-synuclein fragments recovers phenotype of Parkinson\u2019s disease model flies. PLoS One 5(11):e13863. doi: 10.1371\/journal.pone.0013863","journal-title":"PLoS One"},{"issue":"5674","key":"2345_CR27","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"304","author":"JT Greenamyre","year":"2004","unstructured":"Greenamyre JT, Hastings TG (2004) Biomedicine. Parkinson\u2019s\u2014divergent causes, convergent mechanisms. Science 304(5674):1120\u20131122. doi: 10.1126\/science.1098966","journal-title":"Science"},{"issue":"1","key":"2345_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/bfgp\/2.1.72","volume":"2","author":"M Crawford","year":"2003","unstructured":"Crawford M, Woodman R, Ko Ferrigno P (2003) Peptide aptamers: tools for biology and drug discovery. Brief Funct Genom Proteom 2(1):72\u201379","journal-title":"Brief Funct Genom Proteom"},{"issue":"12","key":"2345_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00432-003-0489-8","volume":"129","author":"C Buerger","year":"2003","unstructured":"Buerger C, Groner B (2003) Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling. J Cancer Res Clin Oncol 129(12):669\u2013675. doi: 10.1007\/s00432-003-0489-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"2345_CR30","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/clinchem\/45.9.1628","volume":"45","author":"SD Jayasena","year":"1999","unstructured":"Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45(9):1628\u20131650","journal-title":"Clin Chem"},{"issue":"8","key":"2345_CR31","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.11.8.4104","volume":"11","author":"WE Wright","year":"1991","unstructured":"Wright WE, Binder M, Funk W (1991) Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol Cell Biol 11(8):4104\u20134110","journal-title":"Mol Cell Biol"},{"issue":"4984","key":"2345_CR32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.2174572","volume":"250","author":"TK Blackwell","year":"1990","unstructured":"Blackwell TK, Weintraub H (1990) Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250(4984):1104\u20131110","journal-title":"Science"},{"issue":"6829","key":"2345_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/35070613","volume":"410","author":"AD Keefe","year":"2001","unstructured":"Keefe AD, Szostak JW (2001) Functional proteins from a random-sequence library. Nature 410(6829):715\u2013718. doi: 10.1038\/35070613","journal-title":"Nature"},{"issue":"6","key":"2345_CR34","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1039\/c2an15905h","volume":"137","author":"C Marimuthu","year":"2012","unstructured":"Marimuthu C, Tang TH, Tominaga J, Tan SC, Gopinath SC (2012) Single-stranded DNA (ssDNA) production in DNA aptamer generation. Analyst 137(6):1307\u20131315. doi: 10.1039\/c2an15905h","journal-title":"Analyst"},{"issue":"3","key":"2345_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00216-012-6183-4","volume":"404","author":"M Svobodova","year":"2012","unstructured":"Svobodova M, Pinto A, Nadal P, O\u2019Sullivan CK (2012) Comparison of different methods for generation of single-stranded DNA for SELEX processes. Anal Bioanal Chem 404(3):835\u2013842. doi: 10.1007\/s00216-012-6183-4","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"2345_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bioeng.2007.06.001","volume":"24","author":"R Stoltenburg","year":"2007","unstructured":"Stoltenburg R, Reinemann C, Strehlitz B (2007) SELEX\u2014a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 24(4):381\u2013403. doi: 10.1016\/j.bioeng.2007.06.001","journal-title":"Biomol Eng"},{"key":"2345_CR37","doi-asserted-by":"publisher","DOI":"10.3791\/1955","author":"F Rahimi","year":"2010","unstructured":"Rahimi F, Bitan G (2010) Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer\u2019s disease. J Vis Exp. doi: 10.3791\/1955","journal-title":"J Vis Exp"},{"issue":"13","key":"2345_CR38","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1021\/ac300330g","volume":"84","author":"K Tsukakoshi","year":"2012","unstructured":"Tsukakoshi K, Abe K, Sode K, Ikebukuro K (2012) Selection of DNA aptamers that recognize alpha-synuclein oligomers using a competitive screening method. Anal Chem 84(13):5542\u20135547. doi: 10.1021\/ac300330g","journal-title":"Anal Chem"},{"issue":"6 Pt 2","key":"2345_CR39","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.biotechadv.2015.02.008","volume":"33","author":"M Darmostuk","year":"2015","unstructured":"Darmostuk M, Rimpelova S, Gbelcova H, Ruml T (2015) Current approaches in SELEX: an update to aptamer selection technology. Biotechnol Adv 33(6 Pt 2):1141\u20131161. doi: 10.1016\/j.biotechadv.2015.02.008","journal-title":"Biotechnol Adv"},{"issue":"10","key":"2345_CR40","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1166\/jbn.2014.1979","volume":"10","author":"Z Xi","year":"2014","unstructured":"Xi Z, Huang R, Deng Y, He N (2014) Progress in selection and biomedical applications of aptamers. J Biomed Nanotechnol 10(10):3043\u20133062","journal-title":"J Biomed Nanotechnol"},{"issue":"6","key":"2345_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.bioeng.2007.06.003","volume":"24","author":"Y Yang","year":"2007","unstructured":"Yang Y, Yang D, Schluesener HJ, Zhang Z (2007) Advances in SELEX and application of aptamers in the central nervous system. Biomol Eng 24(6):583\u2013592. doi: 10.1016\/j.bioeng.2007.06.003","journal-title":"Biomol Eng"},{"issue":"18","key":"2345_CR42","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1021\/ac049857v","volume":"76","author":"SD Mendonsa","year":"2004","unstructured":"Mendonsa SD, Bowser MT (2004) In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem 76(18):5387\u20135392. doi: 10.1021\/ac049857v","journal-title":"Anal Chem"},{"issue":"1","key":"2345_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1006\/bbrc.1997.6517","volume":"234","author":"JG Bruno","year":"1997","unstructured":"Bruno JG (1997) In vitro selection of DNA to chloroaromatics using magnetic microbead-based affinity separation and fluorescence detection. Biochem Biophys Res Commun 234(1):117\u2013120. doi: 10.1006\/bbrc.1997.6517","journal-title":"Biochem Biophys Res Commun"},{"key":"2345_CR44","unstructured":"Bruno JG, Kiel JL (2002) Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. BioTech 32 (1):178\u2013180, 182\u2013173"},{"issue":"32","key":"2345_CR45","doi-asserted-by":"publisher","first-page":"9726","DOI":"10.1021\/bi9700633","volume":"36","author":"C Mannironi","year":"1997","unstructured":"Mannironi C, Di Nardo A, Fruscoloni P, Tocchini-Valentini GP (1997) In vitro selection of dopamine RNA ligands. Biochemistry 36(32):9726\u20139734. doi: 10.1021\/bi9700633","journal-title":"Biochemistry"},{"issue":"4","key":"2345_CR46","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/gni044","volume":"33","author":"D Eulberg","year":"2005","unstructured":"Eulberg D, Buchner K, Maasch C, Klussmann S (2005) Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res 33(4):e45. doi: 10.1093\/nar\/gni044","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2345_CR47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1021\/bp980097h","volume":"14","author":"JC Cox","year":"1998","unstructured":"Cox JC, Rudolph P, Ellington AD (1998) Automated RNA selection. Biotechnol Prog 14(6):845\u2013850. doi: 10.1021\/bp980097h","journal-title":"Biotechnol Prog"},{"issue":"10","key":"2345_CR48","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/S0968-0896(01)00028-1","volume":"9","author":"JC Cox","year":"2001","unstructured":"Cox JC, Ellington AD (2001) Automated selection of anti-protein aptamers. Bioorg Med Chem 9(10):2525\u20132531","journal-title":"Bioorg Med Chem"},{"issue":"26","key":"2345_CR49","doi-asserted-by":"publisher","first-page":"15416","DOI":"10.1073\/pnas.2136683100","volume":"100","author":"DA Daniels","year":"2003","unstructured":"Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L (2003) A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA 100(26):15416\u201315421. doi: 10.1073\/pnas.2136683100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2345_CR50","doi-asserted-by":"publisher","first-page":"e100243","DOI":"10.1371\/journal.pone.0100243","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang Y, Luo Y, Bing T, Chen Z, Lu M, Zhang N, Shangguan D, Gao X (2014) DNA aptamer evolved by cell-SELEX for recognition of prostate cancer. PLoS One 9(6):e100243. doi: 10.1371\/journal.pone.0100243","journal-title":"PLoS One"},{"issue":"25","key":"2345_CR51","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1016\/j.biomaterials.2014.04.112","volume":"35","author":"WM Li","year":"2014","unstructured":"Li WM, Bing T, Wei JY, Chen ZZ, Shangguan DH, Fang J (2014) Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells. Biomaterials 35(25):6998\u20137007. doi: 10.1016\/j.biomaterials.2014.04.112","journal-title":"Biomaterials"},{"issue":"6","key":"2345_CR52","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s13346-012-0104-0","volume":"2","author":"A Aravind","year":"2012","unstructured":"Aravind A, Yoshida Y, Maekawa T, Kumar DS (2012) Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy. Drug Del Transl Res 2(6):418\u2013436. doi: 10.1007\/s13346-012-0104-0","journal-title":"Drug Del Transl Res"},{"issue":"3","key":"2345_CR53","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1021\/cn100114k","volume":"2","author":"AT Bayrac","year":"2011","unstructured":"Bayrac AT, Sefah K, Parekh P, Bayrac C, Gulbakan B, Oktem HA, Tan W (2011) In vitro selection of DNA aptamers to glioblastoma multiforme. ACS Chem Neurosci 2(3):175\u2013181. doi: 10.1021\/cn100114k","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"2345_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.yexcr.2016.01.015","volume":"341","author":"AG Souza","year":"2016","unstructured":"Souza AG, Marangoni K, Fujimura PT, Alves PT, Silva MJ, Bastos VA, Goulart LR, Goulart VA (2016) 3D Cell-SELEX: development of RNA aptamers as molecular probes for PC-3 tumor cell line. Exp Cell Res 341(2):147\u2013156. doi: 10.1016\/j.yexcr.2016.01.015","journal-title":"Exp Cell Res"},{"issue":"2","key":"2345_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.biotechadv.2013.10.006","volume":"32","author":"Z Li","year":"2014","unstructured":"Li Z, Cui Z (2014) Three-dimensional perfused cell culture. Biotechnol Adv 32(2):243\u2013254. doi: 10.1016\/j.biotechadv.2013.10.006","journal-title":"Biotechnol Adv"},{"key":"2345_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17030358","author":"Y Yu","year":"2016","unstructured":"Yu Y, Liang C, Lv Q, Li D, Xu X, Liu B, Lu A, Zhang G (2016) Molecular selection, modification and development of therapeutic oligonucleotide aptamers. Int J Mol Sci. doi: 10.3390\/ijms17030358","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2345_CR57","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.coph.2010.06.009","volume":"10","author":"DH Bunka","year":"2010","unstructured":"Bunka DH, Platonova O, Stockley PG (2010) Development of aptamer therapeutics. Curr Opin Pharmacol 10(5):557\u2013562. doi: 10.1016\/j.coph.2010.06.009","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"2345_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nbt0502-448","volume":"20","author":"M Famulok","year":"2002","unstructured":"Famulok M (2002) Bringing picomolar protein detection into proximity. Nat Biotechnol 20(5):448\u2013449. doi: 10.1038\/nbt0502-448","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2345_CR59","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/ar700142z","volume":"41","author":"SM Shamah","year":"2008","unstructured":"Shamah SM, Healy JM, Cload ST (2008) Complex target SELEX. Acc Chem Res 41(1):130\u2013138. doi: 10.1021\/ar700142z","journal-title":"Acc Chem Res"},{"issue":"6437","key":"2345_CR60","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/364550a0","volume":"364","author":"M Sassanfar","year":"1993","unstructured":"Sassanfar M, Szostak JW (1993) An RNA motif that binds ATP. Nature 364(6437):550\u2013553. doi: 10.1038\/364550a0","journal-title":"Nature"},{"issue":"3","key":"2345_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2217\/fon.12.201","volume":"9","author":"M Hu","year":"2013","unstructured":"Hu M, Zhang K (2013) The application of aptamers in cancer research: an up-to-date review. Future Oncol 9(3):369\u2013376. doi: 10.2217\/fon.12.201","journal-title":"Future Oncol"},{"issue":"27","key":"2345_CR62","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.2174\/092986711797189646","volume":"18","author":"Y Yang","year":"2011","unstructured":"Yang Y, Ren X, Schluesener HJ, Zhang Z (2011) Aptamers: selection, modification and application to nervous system diseases. Curr Med Chem 18(27):4159\u20134168","journal-title":"Curr Med Chem"},{"issue":"7","key":"2345_CR63","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrd3141","volume":"9","author":"AD Keefe","year":"2010","unstructured":"Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9(7):537\u2013550. doi: 10.1038\/nrd3141","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2345_CR64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.32607\/20758251-2013-5-4-34-43","volume":"5","author":"AV Lakhin","year":"2013","unstructured":"Lakhin AV, Tarantul VZ, Gening LV (2013) Aptamers: problems, solutions and prospects. Acta Nat 5(4):34\u201343","journal-title":"Acta Nat"},{"issue":"19","key":"2345_CR65","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1093\/nar\/gkh862","volume":"32","author":"KS Schmidt","year":"2004","unstructured":"Schmidt KS, Borkowski S, Kurreck J, Stephens AW, Bald R, Hecht M, Friebe M, Dinkelborg L, Erdmann VA (2004) Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res 32(19):5757\u20135765. doi: 10.1093\/nar\/gkh862","journal-title":"Nucleic Acids Res"},{"issue":"41","key":"2345_CR66","doi-asserted-by":"publisher","first-page":"39697","DOI":"10.1074\/jbc.M305297200","volume":"278","author":"A Rhie","year":"2003","unstructured":"Rhie A, Kirby L, Sayer N, Wellesley R, Disterer P, Sylvester I, Gill A, Hope J, James W, Tahiri-Alaoui A (2003) Characterization of 2\u2032-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem 278(41):39697\u201339705. doi: 10.1074\/jbc.M305297200","journal-title":"J Biol Chem"},{"key":"2345_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2016.03.008","author":"KN Meek","year":"2016","unstructured":"Meek KN, Rangel AE, Heemstra JM (2016) Enhancing aptamer function and stability via in vitro selection using modified nucleic acids. Methods. doi: 10.1016\/j.ymeth.2016.03.008","journal-title":"Methods"},{"issue":"7","key":"2345_CR68","doi-asserted-by":"publisher","first-page":"11959","DOI":"10.3390\/molecules200711959","volume":"20","author":"H Sun","year":"2015","unstructured":"Sun H, Zu Y (2015) A highlight of recent advances in aptamer technology and its application. Molecules 20(7):11959\u201311980. doi: 10.3390\/molecules200711959","journal-title":"Molecules"},{"issue":"2","key":"2345_CR69","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0167-7799(02)00038-0","volume":"21","author":"M Petersen","year":"2003","unstructured":"Petersen M, Wengel J (2003) LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol 21(2):74\u201381. doi: 10.1016\/S0167-7799(02)00038-0","journal-title":"Trends Biotechnol"},{"issue":"2","key":"2345_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/oli.1.2000.10.63","volume":"10","author":"SR Watson","year":"2000","unstructured":"Watson SR, Chang YF, O\u2019Connell D, Weigand L, Ringquist S, Parma DH (2000) Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo. Antisense Nucleic Acid Drug Dev 10(2):63\u201375. doi: 10.1089\/oli.1.2000.10.63","journal-title":"Antisense Nucleic Acid Drug Dev"},{"issue":"3","key":"2345_CR71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0969-8051(99)00103-1","volume":"27","author":"H Dougan","year":"2000","unstructured":"Dougan H, Lyster DM, Vo CV, Stafford A, Weitz JI, Hobbs JB (2000) Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood. Nucl Med Biol 27(3):289\u2013297","journal-title":"Nucl Med Biol"},{"issue":"17","key":"2345_CR72","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1093\/nar\/19.17.4695","volume":"19","author":"PC Smidt de","year":"1991","unstructured":"de Smidt PC, Le Doan T, de Falco S, van Berkel TJ (1991) Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acids Res 19(17):4695\u20134700","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2345_CR73","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrd1955","volume":"5","author":"EW Ng","year":"2006","unstructured":"Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5(2):123\u2013132. doi: 10.1038\/nrd1955","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"2345_CR74","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2165\/00003495-200565110-00010","volume":"65","author":"MA Siddiqui","year":"2005","unstructured":"Siddiqui MA, Keating GM (2005) Pegaptanib: in exudative age-related macular degeneration. Drugs 65(11):1571\u20131577 (discussion 1578\u20131579)","journal-title":"Drugs"},{"issue":"8","key":"2345_CR75","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nbt1223","volume":"24","author":"JO McNamara 2nd","year":"2006","unstructured":"McNamara JO 2nd, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24(8):1005\u20131015. doi: 10.1038\/nbt1223","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2345_CR76","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1158\/0008-5472.CAN-05-4583","volume":"66","author":"TC Chu","year":"2006","unstructured":"Chu TC, Marks JW 3rd, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, Levy M (2006) Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res 66(12):5989\u20135992. doi: 10.1158\/0008-5472.CAN-05-4583","journal-title":"Cancer Res"},{"issue":"15","key":"2345_CR77","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1039\/c6nr00369a","volume":"8","author":"XW Wang","year":"2016","unstructured":"Wang XW, Gao W, Fan H, Ding D, Lai XF, Zou YX, Chen L, Chen Z, Tan W (2016) Simultaneous tracking of drug molecules and carriers using aptamer-functionalized fluorescent superstable gold nanorod-carbon nanocapsules during thermo-chemotherapy. Nanoscale 8(15):7942\u20137948. doi: 10.1039\/c6nr00369a","journal-title":"Nanoscale"},{"key":"2345_CR78","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.colsurfb.2016.02.058","volume":"143","author":"M Azhdarzadeh","year":"2016","unstructured":"Azhdarzadeh M, Atyabi F, Saei AA, Varnamkhasti BS, Omidi Y, Fateh M, Ghavami M, Shanehsazzadeh S, Dinarvand R (2016) Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer. Colloids Surf B 143:224\u2013232. doi: 10.1016\/j.colsurfb.2016.02.058","journal-title":"Colloids Surf B"},{"issue":"10","key":"2345_CR79","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1002\/asia.201500434","volume":"10","author":"S Cansiz","year":"2015","unstructured":"Cansiz S, Zhang L, Wu C, Wu Y, Teng IT, Hou W, Wang Y, Wan S, Cai R, Jin C, Liu Q, Tan W (2015) DNA aptamer based nanodrugs: molecular engineering for efficiency. Chem Asian J 10(10):2084\u20132094. doi: 10.1002\/asia.201500434","journal-title":"Chem Asian J"},{"issue":"6","key":"2345_CR80","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1021\/ar500078f","volume":"47","author":"H Liang","year":"2014","unstructured":"Liang H, Zhang XB, Lv Y, Gong L, Wang R, Zhu X, Yang R, Tan W (2014) Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy. Acc Chem Res 47(6):1891\u20131901. doi: 10.1021\/ar500078f","journal-title":"Acc Chem Res"},{"issue":"5","key":"2345_CR81","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","volume":"83","author":"L Zhang","year":"2008","unstructured":"Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83(5):761\u2013769. doi: 10.1038\/sj.clpt.6100400","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"2345_CR82","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.biomaterials.2010.01.009","volume":"31","author":"R Tong","year":"2010","unstructured":"Tong R, Yala L, Fan TM, Cheng J (2010) The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials 31(11):3043\u20133053. doi: 10.1016\/j.biomaterials.2010.01.009","journal-title":"Biomaterials"},{"issue":"21","key":"2345_CR83","doi-asserted-by":"publisher","first-page":"7668","DOI":"10.1158\/0008-5472.CAN-04-2550","volume":"64","author":"OC Farokhzad","year":"2004","unstructured":"Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R (2004) Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 64(21):7668\u20137672. doi: 10.1158\/0008-5472.CAN-04-2550","journal-title":"Cancer Res"},{"issue":"24","key":"2345_CR84","doi-asserted-by":"publisher","first-page":"10013","DOI":"10.1021\/ac901889s","volume":"81","author":"G Liu","year":"2009","unstructured":"Liu G, Mao X, Phillips JA, Xu H, Tan W, Zeng L (2009) Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem 81(24):10013\u201310018. doi: 10.1021\/ac901889s","journal-title":"Anal Chem"},{"issue":"31","key":"2345_CR85","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1016\/j.biomaterials.2011.07.004","volume":"32","author":"J Guo","year":"2011","unstructured":"Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H (2011) Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32(31):8010\u20138020. doi: 10.1016\/j.biomaterials.2011.07.004","journal-title":"Biomaterials"},{"issue":"43","key":"2345_CR86","doi-asserted-by":"publisher","first-page":"16034","DOI":"10.1021\/ja408485m","volume":"135","author":"BR Li","year":"2013","unstructured":"Li BR, Hsieh YJ, Chen YX, Chung YT, Pan CY, Chen YT (2013) An ultrasensitive nanowire-transistor biosensor for detecting dopamine release from living PC12 cells under hypoxic stimulation. J Am Chem Soc 135(43):16034\u201316037. doi: 10.1021\/ja408485m","journal-title":"J Am Chem Soc"},{"issue":"31","key":"2345_CR87","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1016\/j.biomaterials.2012.07.011","volume":"33","author":"P Gong","year":"2012","unstructured":"Gong P, Shi B, Zheng M, Wang B, Zhang P, Hu D, Gao D, Sheng Z, Zheng C, Ma Y, Cai L (2012) PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imaging. Biomaterials 33(31):7810\u20137817. doi: 10.1016\/j.biomaterials.2012.07.011","journal-title":"Biomaterials"},{"issue":"31","key":"2345_CR88","doi-asserted-by":"publisher","first-page":"7978","DOI":"10.1016\/j.biomaterials.2011.07.011","volume":"32","author":"JM Li","year":"2011","unstructured":"Li JM, Zhao MX, Su H, Wang YY, Tan CP, Ji LN, Mao ZW (2011) Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging. Biomaterials 32(31):7978\u20137987. doi: 10.1016\/j.biomaterials.2011.07.011","journal-title":"Biomaterials"},{"issue":"1","key":"2345_CR89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jconrel.2010.07.109","volume":"148","author":"M Piest","year":"2010","unstructured":"Piest M, Engbersen JF (2010) Effects of charge density and hydrophobicity of poly(amido amine)s for non-viral gene delivery. J Control Rel 148(1):83\u201390. doi: 10.1016\/j.jconrel.2010.07.109","journal-title":"J Control Rel"},{"issue":"10","key":"2345_CR90","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/bip.21032","volume":"89","author":"H Mok","year":"2008","unstructured":"Mok H, Park TG (2008) Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers 89(10):881\u2013888. doi: 10.1002\/bip.21032","journal-title":"Biopolymers"},{"issue":"15","key":"2345_CR91","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","volume":"65","author":"CN Landen Jr","year":"2005","unstructured":"Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK (2005) Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65(15):6910\u20136918. doi: 10.1158\/0008-5472.CAN-05-0530","journal-title":"Cancer Res"},{"issue":"4","key":"2345_CR92","doi-asserted-by":"publisher","first-page":"282","DOI":"10.14336\/AD.2014.002","volume":"6","author":"S Chakrabarti","year":"2015","unstructured":"Chakrabarti S, Khemka VK, Banerjee A, Chatterjee G, Ganguly A, Biswas A (2015) Metabolic risk factors of sporadic Alzheimer\u2019s disease: implications in the pathology, pathogenesis and treatment. Aging Dis 6(4):282\u2013299. doi: 10.14336\/AD.2014.002","journal-title":"Aging Dis"},{"issue":"1","key":"2345_CR93","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nn.4188","volume":"19","author":"U Das","year":"2016","unstructured":"Das U, Wang L, Ganguly A, Saikia JM, Wagner SL, Koo EH, Roy S (2016) Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci 19(1):55\u201364. doi: 10.1038\/nn.4188","journal-title":"Nat Neurosci"},{"issue":"10","key":"2345_CR94","doi-asserted-by":"publisher","first-page":"e0140733","DOI":"10.1371\/journal.pone.0140733","volume":"10","author":"H Liang","year":"2015","unstructured":"Liang H, Shi Y, Kou Z, Peng Y, Chen W, Li X, Li S, Wang Y, Wang F, Zhang X (2015) Inhibition of BACE1 activity by a DNA aptamer in an Alzheimer\u2019s disease cell model. PLoS One 10(10):e0140733. doi: 10.1371\/journal.pone.0140733","journal-title":"PLoS One"},{"issue":"9","key":"2345_CR95","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1261\/rna.126306","volume":"12","author":"A Rentmeister","year":"2006","unstructured":"Rentmeister A, Bill A, Wahle T, Walter J, Famulok M (2006) RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro. RNA 12(9):1650\u20131660. doi: 10.1261\/rna.126306","journal-title":"RNA"},{"issue":"11","key":"2345_CR96","doi-asserted-by":"publisher","first-page":"e7694","DOI":"10.1371\/journal.pone.0007694","volume":"4","author":"F Rahimi","year":"2009","unstructured":"Rahimi F, Murakami K, Summers JL, Chen CH, Bitan G (2009) RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity. PLoS One 4(11):e7694. doi: 10.1371\/journal.pone.0007694","journal-title":"PLoS One"},{"issue":"7233","key":"2345_CR97","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Lauren","year":"2009","unstructured":"Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457(7233):1128\u20131132. doi: 10.1038\/nature07761","journal-title":"Nature"},{"issue":"18","key":"2345_CR98","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1093\/nar\/gkp647","volume":"37","author":"T Mashima","year":"2009","unstructured":"Mashima T, Matsugami A, Nishikawa F, Nishikawa S, Katahira M (2009) Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res 37(18):6249\u20136258. doi: 10.1093\/nar\/gkp647","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2345_CR99","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","volume":"11","author":"TT Du","year":"2015","unstructured":"Du TT, Wang L, Duan CL, Lu LL, Zhang JL, Gao G, Qiu XB, Wang XM, Yang H (2015) GBA deficiency promotes SNCA\/alpha-synuclein accumulation through autophagic inhibition by inactivated PPP2A. Autophagy 11(10):1803\u20131820. doi: 10.1080\/15548627.2015.1086055","journal-title":"Autophagy"},{"key":"2345_CR100","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","volume":"26","author":"PK Auluck","year":"2010","unstructured":"Auluck PK, Caraveo G, Lindquist S (2010) alpha-Synuclein: membrane interactions and toxicity in Parkinson\u2019s disease. Annu Rev Cell Dev Biol 26:211\u2013233. doi: 10.1146\/annurev.cellbio.042308.113313","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2345_CR101","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-016-9743-3","author":"J Zhao","year":"2016","unstructured":"Zhao J, Yu S, Zheng Y, Yang H, Zhang J (2016) Oxidative modification and its implications for the neurodegeneration of Parkinson\u2019s disease. Mol Neurobiol. doi: 10.1007\/s12035-016-9743-3","journal-title":"Mol Neurobiol"},{"key":"2345_CR102","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.arr.2013.12.009","volume":"13","author":"M Bisaglia","year":"2014","unstructured":"Bisaglia M, Filograna R, Beltramini M, Bubacco L (2014) Are dopamine derivatives implicated in the pathogenesis of Parkinson\u2019s disease? Ageing Res Rev 13:107\u2013114. doi: 10.1016\/j.arr.2013.12.009","journal-title":"Ageing Res Rev"},{"issue":"6147","key":"2345_CR103","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1126\/science.1243619","volume":"341","author":"F Kamel","year":"2013","unstructured":"Kamel F (2013) Epidemiology. Paths from pesticides to Parkinson\u2019s. Science 341(6147):722\u2013723. doi: 10.1126\/science.1243619","journal-title":"Science"},{"issue":"6248","key":"2345_CR104","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M (2015) NEURODEGENERATION. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 349(6248):1255555. doi: 10.1126\/science.1255555","journal-title":"Science"},{"issue":"6","key":"2345_CR105","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molmed.2013.04.002","volume":"19","author":"A Deleersnijder","year":"2013","unstructured":"Deleersnijder A, Gerard M, Debyser Z, Baekelandt V (2013) The remarkable conformational plasticity of alpha-synuclein: blessing or curse? Trends Mol Med 19(6):368\u2013377. doi: 10.1016\/j.molmed.2013.04.002","journal-title":"Trends Mol Med"},{"issue":"12","key":"2345_CR106","doi-asserted-by":"publisher","first-page":"e14292","DOI":"10.1371\/journal.pone.0014292","volume":"5","author":"BD Rooijen van","year":"2010","unstructured":"van Rooijen BD, Claessens MM, Subramaniam V (2010) Membrane permeabilization by oligomeric alpha-synuclein: in search of the mechanism. PLoS One 5(12):e14292. doi: 10.1371\/journal.pone.0014292","journal-title":"PLoS One"},{"issue":"20","key":"2345_CR107","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","volume":"28","author":"DP Karpinar","year":"2009","unstructured":"Karpinar DP, Balija MB, Kugler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, Kumar A, Riedel D, Fichtner L, Voigt A, Braus GH, Giller K, Becker S, Herzig A, Baldus M, Jackle H, Eimer S, Schulz JB, Griesinger C, Zweckstetter M (2009) Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models. EMBO J 28(20):3256\u20133268. doi: 10.1038\/emboj.2009.257","journal-title":"EMBO J"},{"issue":"16","key":"2345_CR108","doi-asserted-by":"publisher","first-page":"10992","DOI":"10.1074\/jbc.M709634200","volume":"283","author":"M Kostka","year":"2008","unstructured":"Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, Wirth A, Wagner R, Glabe CG, Finger S, Heinzelmann U, Garidel P, Duan W, Ross CA, Kretzschmar H, Giese A (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283(16):10992\u201311003. doi: 10.1074\/jbc.M709634200","journal-title":"J Biol Chem"},{"issue":"7","key":"2345_CR109","doi-asserted-by":"publisher","first-page":"9514","DOI":"10.3390\/s120709514","volume":"12","author":"CH Weng","year":"2012","unstructured":"Weng CH, Huang CJ, Lee GB (2012) Screening of aptamers on microfluidic systems for clinical applications. Sensors 12(7):9514\u20139529. doi: 10.3390\/s120709514","journal-title":"Sensors"},{"issue":"12","key":"2345_CR110","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","volume":"8","author":"MC Rodriguez-Oroz","year":"2009","unstructured":"Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms. Lancet Neurol 8(12):1128\u20131139. doi: 10.1016\/S1474-4422(09)70293-5","journal-title":"Lancet Neurol"},{"issue":"2","key":"2345_CR111","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bioelechem.2006.05.011","volume":"70","author":"J Zheng","year":"2007","unstructured":"Zheng J, Zhou X (2007) Sodium dodecyl sulfate-modified carbon paste electrodes for selective determination of dopamine in the presence of ascorbic acid. Bioelectrochemistry 70(2):408\u2013415. doi: 10.1016\/j.bioelechem.2006.05.011","journal-title":"Bioelectrochemistry"},{"issue":"6","key":"2345_CR112","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.neuropharm.2005.11.022","volume":"50","author":"CJ Swanson","year":"2006","unstructured":"Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP (2006) Effect of the attention deficit\/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 50(6):755\u2013760. doi: 10.1016\/j.neuropharm.2005.11.022","journal-title":"Neuropharmacology"},{"issue":"1","key":"2345_CR113","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/187152706784111560","volume":"5","author":"T Kienast","year":"2006","unstructured":"Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5(1):109\u2013131","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"2345_CR114","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bios.2012.04.011","volume":"36","author":"S Liu","year":"2012","unstructured":"Liu S, Xing X, Yu J, Lian W, Li J, Cui M, Huang J (2012) A novel label-free electrochemical aptasensor based on graphene-polyaniline composite film for dopamine determination. Biosens Bioelectron 36(1):186\u2013191. doi: 10.1016\/j.bios.2012.04.011","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"2345_CR115","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1021\/ac302134s","volume":"85","author":"E Farjami","year":"2013","unstructured":"Farjami E, Campos R, Nielsen JS, Gothelf KV, Kjems J, Ferapontova EE (2013) RNA aptamer-based electrochemical biosensor for selective and label-free analysis of dopamine. Anal Chem 85(1):121\u2013128. doi: 10.1021\/ac302134s","journal-title":"Anal Chem"},{"issue":"7","key":"2345_CR116","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nn.3120","volume":"15","author":"A Aguzzi","year":"2012","unstructured":"Aguzzi A, Falsig J (2012) Prion propagation, toxicity and degradation. Nat Neurosci 15(7):936\u2013939. doi: 10.1038\/nn.3120","journal-title":"Nat Neurosci"},{"issue":"23","key":"2345_CR117","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95(23):13363\u201313383","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"2345_CR118","doi-asserted-by":"publisher","first-page":"13102","DOI":"10.1074\/jbc.M310928200","volume":"279","author":"NM Sayer","year":"2004","unstructured":"Sayer NM, Cubin M, Rhie A, Bullock M, Tahiri-Alaoui A, James W (2004) Structural determinants of conformationally selective, prion-binding aptamers. J Biol Chem 279(13):13102\u201313109. doi: 10.1074\/jbc.M310928200","journal-title":"J Biol Chem"},{"issue":"4","key":"2345_CR119","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4161\/pri.1.4.5803","volume":"1","author":"D Ogasawara","year":"2014","unstructured":"Ogasawara D, Hasegawa H, Kaneko K, Sode K, Ikebukuro K (2014) Screening of DNA aptamer against mouse prion protein by competitive selection. Prion 1(4):248\u2013254. doi: 10.4161\/pri.1.4.5803","journal-title":"Prion"},{"issue":"3","key":"2345_CR120","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jb\/mvj046","volume":"139","author":"S Sekiya","year":"2006","unstructured":"Sekiya S, Noda K, Nishikawa F, Yokoyama T, Kumar PK, Nishikawa S (2006) Characterization and application of a novel RNA aptamer against the mouse prion protein. J Biochem 139(3):383\u2013390. doi: 10.1093\/jb\/mvj046","journal-title":"J Biochem"},{"issue":"2","key":"2345_CR121","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/153537020623100211","volume":"231","author":"K Takemura","year":"2006","unstructured":"Takemura K, Wang P, Vorberg I, Surewicz W, Priola SA, Kanthasamy A, Pottathil R, Chen SG, Sreevatsan S (2006) DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity. Exp Biol Med 231(2):204\u2013214","journal-title":"Exp Biol Med"},{"issue":"11","key":"2345_CR122","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00705-006-0790-3","volume":"151","author":"R Mercey","year":"2006","unstructured":"Mercey R, Lantier I, Maurel MC, Grosclaude J, Lantier F, Marc D (2006) Fast, reversible interaction of prion protein with RNA aptamers containing specific sequence patterns. Arch Virol 151(11):2197\u20132214. doi: 10.1007\/s00705-006-0790-3","journal-title":"Arch Virol"},{"issue":"8","key":"2345_CR123","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(10)70160-5","volume":"9","author":"L Spinney","year":"2010","unstructured":"Spinney L (2010) Uncovering the true prevalence of Huntington\u2019s disease. Lancet Neurol 9(8):760\u2013761. doi: 10.1016\/S1474-4422(10)70160-5","journal-title":"Lancet Neurol"},{"issue":"2","key":"2345_CR124","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1172\/JCI45364","volume":"121","author":"I Munoz-Sanjuan","year":"2011","unstructured":"Munoz-Sanjuan I, Bates GP (2011) The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. J Clin Investig 121(2):476\u2013483. doi: 10.1172\/JCI45364","journal-title":"J Clin Investig"},{"key":"2345_CR125","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2202-7-65","volume":"7","author":"M Skogen","year":"2006","unstructured":"Skogen M, Roth J, Yerkes S, Parekh-Olmedo H, Kmiec E (2006) Short G-rich oligonucleotides as a potential therapeutic for Huntington\u2019s Disease. BMC Neurosci 7:65. doi: 10.1186\/1471-2202-7-65","journal-title":"BMC Neurosci"},{"issue":"4","key":"2345_CR126","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/nat.2014.0529","volume":"25","author":"W Li","year":"2015","unstructured":"Li W, Lan X (2015) Aptamer oligonucleotides: novel potential therapeutic agents in autoimmune disease. Nucleic acid Therap 25(4):173\u2013179. doi: 10.1089\/nat.2014.0529","journal-title":"Nucleic acid Therap"},{"issue":"2","key":"2345_CR127","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/nar\/gks1093","volume":"41","author":"J Smestad","year":"2013","unstructured":"Smestad J, Maher LJ 3rd (2013) Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis. Nucleic Acids Res 41(2):1329\u20131342. doi: 10.1093\/nar\/gks1093","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2345_CR128","doi-asserted-by":"publisher","first-page":"e39595","DOI":"10.1371\/journal.pone.0039595","volume":"7","author":"B Nastasijevic","year":"2012","unstructured":"Nastasijevic B, Wright BR, Smestad J, Warrington AE, Rodriguez M, Maher LJ 3rd (2012) Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. PLoS One 7(6):e39595. doi: 10.1371\/journal.pone.0039595","journal-title":"PLoS One"},{"key":"2345_CR129","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1038\/mtna.2014.43","volume":"3","author":"GT Rozenblum","year":"2014","unstructured":"Rozenblum GT, Kaufman T, Vitullo AD (2014) Myelin basic protein and a multiple sclerosis-related MBP-peptide bind to oligonucleotides. Mol Ther Nucleic Acids 3:e192. doi: 10.1038\/mtna.2014.43","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"2345_CR130","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1021\/nn200693a","volume":"5","author":"M Chang","year":"2011","unstructured":"Chang M, Yang CS, Huang DM (2011) Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy. ACS Nano 5(8):6156\u20136163. doi: 10.1021\/nn200693a","journal-title":"ACS Nano"},{"issue":"10","key":"2345_CR131","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/asia.201000242","volume":"5","author":"H Shi","year":"2010","unstructured":"Shi H, Tang Z, Kim Y, Nie H, Huang YF, He X, Deng K, Wang K, Tan W (2010) In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX. Chem Asian J 5(10):2209\u20132213. doi: 10.1002\/asia.201000242","journal-title":"Chem Asian J"},{"issue":"9","key":"2345_CR132","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nbt0996-1116","volume":"14","author":"A Nolte","year":"1996","unstructured":"Nolte A, Klussmann S, Bald R, Erdmann VA, Furste JP (1996) Mirror-design of l-oligonucleotide ligands binding to l-arginine. Nat Biotechnol 14(9):1116\u20131119. doi: 10.1038\/nbt0996-1116","journal-title":"Nat Biotechnol"},{"issue":"52","key":"2345_CR133","doi-asserted-by":"publisher","first-page":"48644","DOI":"10.1074\/jbc.M104651200","volume":"276","author":"BJ Hicke","year":"2001","unstructured":"Hicke BJ, Marion C, Chang YF, Gould T, Lynott CK, Parma D, Schmidt PG, Warren S (2001) Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem 276(52):48644\u201348654. doi: 10.1074\/jbc.M104651200","journal-title":"J Biol Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-016-2345-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2345-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-016-2345-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T14:22:26Z","timestamp":1601043746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-016-2345-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s00018-016-2345-4","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]}}}